COMMUNIQUÉS West-GlobeNewswire

Genocea Presents New Data Demonstrating the Power and Versatility of its ATLAS™ Antigen Identification Platform at SITC 2017
07/11/2017
- ATLAS continues to demonstrate superiority to in silico methods of neoantigen identification in multiple tumor types - - ATLAS also identifies unique tumor-associated antigen response signatures in patients with lung [...]
Novan Announces Plan to Complete Development of SB204 Acne Candidate via Third Party Funding and Execution
07/11/2017
MORRISVILLE, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ: NOVN ) today announced that it has agreed in principle to a business structure that would enable further development [...]
Celldex Reports Third Quarter 2017 Results
07/11/2017
HAMPTON, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX ) today reported business and financial highlights for the third quarter ended September 30, 2017. "In late August, we completed [...]
Initial Results from Phase 2 Study of CB-839 in Combination with Opdivo® (nivolumab) to be Presented at the Society for Immunotherapy of Cancer Meeting
07/11/2017
Achieved confirmed responses in melanoma patients progressing on PD-1/PD-L1 therapy Expanding Bristol-Myers Squibb clinical collaboration SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Calithera [...]
HempAmericana Provides Critical Shareholder Update
07/11/2017
NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (the “Company”) is excited to provide a critical shareholder update as the Company continues to ramp operations at its Portland, Maine facility [...]
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017
07/11/2017
NORTHVALE, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche [...]
Immune Design Announces Multiple Presentations at CTOS and SITC Highlighting the Breadth of Existing & Future Product Candidates
07/11/2017
SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ ), a clinical-stage immunotherapy company focused on oncology, today announced seven presentations at the upcoming [...]
Atara Biotherapeutics to Participate in Four Upcoming Investor Conferences
07/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]
Chalice Farms Announces New Seasonal Cannabis Edibles
07/11/2017
Portland, Oregon-based dispensary chain, part of the Golden Leaf Holdings portfolio of brands, unveils line of Pumpkin Spice Cannabis Truffles and Cannabis-Infused Dark Chocolate Peppermint for fall and holiday season
Proteon Therapeutics Announces Third Quarter 2017 Financial Results
07/11/2017
WALTHAM, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO ), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
Chimerix to Present at the Stifel 2017 Healthcare Conference
07/11/2017
DURHAM, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey, M.D., M.P.H., [...]
Cannabix Technologies Files THC Based Ignition Interlock Patent Application and Provides Update on Marijuana Breathalyzer Development
07/11/2017
VANCOUVER, British Columbia, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and [...]
Neos Therapeutics to Present at the Stifel 2017 Healthcare Conference
07/11/2017
DALLAS/FORT WORTH, Texas, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release (XR) [...]
CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor Reception at the 32nd Annual Society for Immunotherapy of Cancer Meeting
07/11/2017
ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a genome editing company focused on creating transformative medicine for serious diseases, today announced [...]
OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform
07/11/2017
MIAMI, Nov. 07, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ) ("OPKO" or "the Company") announces the filing of a Premarket Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the [...]
G1 Therapeutics to Present at Stifel 2017 Healthcare Conference
07/11/2017
RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ: GTHX ), a clinical-stage oncology company, announced today that Chief Executive Officer Mark Velleca, MD, PhD, will present [...]
Portola Pharmaceuticals Announces New APEX Study Sub-Analyses Data on Betrixaban to be Presented at the America Heart Association (AHA) Scientific Sessions 2017
07/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. ® (Nasdaq: PTLA ) today announced that results of new sub-analyses of the APEX Study of betrixaban will be presented in oral [...]
Aptose To Release Third Quarter Ended September 30, 2017 Financial Results and Hold Conference Call on November 14, 2017
07/11/2017
SAN DIEGO and TORONTO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics targeting the underlying [...]
Spring Bank to Present at Piper Jaffray’s 29th Annual Healthcare Conference
07/11/2017
HOPKINTON, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]

Pages